Research Brief
Using Outcomes to Assess Teen Substance-Use Treatment Programs -- How Feasible?
Jul 11, 2007
Format | File Size | Notes |
---|---|---|
PDF file | 0.7 MB | Use Adobe Acrobat Reader version 10 or higher for the best experience. |
Format | File Size | Notes |
---|---|---|
PDF file | 0.2 MB | Use Adobe Acrobat Reader version 10 or higher for the best experience. |
Format | List Price | Price | |
---|---|---|---|
Add to Cart | Paperback124 pages | $20.00 | $16.00 20% Web Discount |
Each year, substance abuse treatment programs in the United States record approximately 150,000 admissions of youths under the age of 18. Nevertheless, little is known about the effectiveness of the types of community-based services typically available to youths and their families. Researchers interviewed youths treated in 11 adolescent programs that had been identified as having suggestive evidence of effectiveness, in order to learn whether they had better outcomes a year after treatment admission than they would have had at other facilities. The study failed to find strong and persuasive evidence of greater treatment effectiveness at the facilities studied. Relative effectiveness may be difficult to measure because facilities serve different populations, because the study examined relative rather than absolute treatment effects, or because large and significant treatment effects might exist for each evaluated treatment program but might be no longer detectable a year after admission. However, there were consistently small positive effects for direct measures of substance use.
Chapter One
Introduction
Chapter Two
The ATM Programs
Chapter Three
Case-Mix Adjustment Approach
Chapter Four
Study Procedures
Chapter Five
Case-Mix Adjusted Comparison Samples
Chapter Six
Outcomes
Chapter Seven
Discussion
Appendix
Supporting Tables
The research described in this report was prepared for the Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment and was carried out under the auspices of the RAND Drug Policy Research Center, a joint endeavor of RAND Infrastructure, Safety, and Environment (ISE) and RAND Health.
This report is part of the RAND Corporation Technical report series. RAND technical reports may include research findings on a specific topic that is limited in scope or intended for a narrow audience; present discussions of the methodology employed in research; provide literature reviews, survey instruments, modeling exercises, guidelines for practitioners and research professionals, and supporting documentation; or deliver preliminary findings. All RAND reports undergo rigorous peer review to ensure that they meet high standards for research quality and objectivity.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.